2

❤️

An article in Forbes written by Gregory Ferenstein

I was shopping for thanksgiving items and found a National Geographic Magazine Dedicated to Cannabis/marijuana

Today you would have been 73

I flipped through Time Magazines new mental health edition and found an article on psilocybin for depression cancer anxiety

I start off by giving information about DOM and Erowid trip report to go with it, but Then I trail off into a semi incoherent ramble about my battles with drug addiction and the pursuit of edgy cognitive hallucinations

Antipsychotic drugs of all kinds with severe side effects seem to have no trouble getting clinical approval...why are psychedelic drugs having so much difficulty in achieving the same status even though they have a much safer profile and a much greater potential for faster long lasting treatment

Methylisopropyllysergamide (lysergic acid methylisopropyl amide, MIPLA) is an analogue of LSD that was originally discovered by Albert Hofmann at Sandoz during the original structure-activity research into LSD. It has subsequently been investigated in more detail by the team led by David E. Nichols at Purdue University. Methylisopropyllysergamide is a structural isomer of LSD, with the alkyl groups on the amide nitrogen having been subjected to a methylene shuffle. An experience report from Erowid.org to follow up the chemistry

This episode We check out a legal analog of LSD-25, a little history of its creation and an experience report from Erowid to top it all off